This piece explores the evolving role of AI across the drug development continuum—from explainable ML models to immune digital twins. The article reinforces that scientific rigor and innovation go hand in hand. AI tools are accelerating time to insight, helping teams make smarter, faster, and more ethical decisions in complex therapeutic areas.